Group 2:Metformin
Sponsors
Department of Endocrinology and Metabolism, Zhongshan Hospital Xiamen University, Henan Provincial People's Hospital, the First People's Hospital of Xiangtan City, Guangdong Maternal and Children Health Care Center, Beijing Hospital
Conditions
Polycystic ovary syndromediabetespatients with new-onset type 2 diabetes and risk factor for atherosclerotic cardiovascular diseasetype 2 diabetes
Phase 4
The effects of liraglutide on beta-cell function and its mechanisms in young patients with new-onset type 2 diabetes
Active, not recruitingChiCTR1800018008
Start: 2015-04-01Updated: 2018-09-03
Comparison of acarbose and metformin therapy on the efficacy of HbA1C, islet function and body weight in newly diagnosed elderly type 2 diabetic patients
RecruitingChiCTR1900021632
Start: 2019-03-18Updated: 2019-03-04
Effects of polyethylene glycol losenatide injection and metformin on intestinal microbiota structure in overweight patients with type 2 diabetes mellitus
Active, not recruitingChiCTR2200057155
Start: 2022-03-01Updated: 2023-10-03
Unknown Phase
Clinical efficacy and mechanism of Empagliflozin in the treatment of patients with new-onset type 2 diabetes and risk factor for atherosclerotic cardiovascular disease
Active, not recruitingChiCTR1800018825
Start: 2018-11-01Updated: 2019-10-14
A multicenter prospective cohort study of lifestyle interventions in patients with insulin-resistant PCOS
Active, not recruitingChiCTR1900027670
Start: 2019-12-01Updated: 2019-11-25